Together, these results suggest that tumor acidosis-mediated decrease of the BMAL1 promotes tumor metastatic potency in breast cancer cell lines, and selectively targeting tumor acidosis to maintain BMAL1 prevents breast cancer metastasis. This evidence concerns the gene BMAL1 and breast carcinoma.